1. Home
  2. ORC vs EYPT Comparison

ORC vs EYPT Comparison

Compare ORC & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orchid Island Capital Inc.

ORC

Orchid Island Capital Inc.

HOLD

Current Price

$6.94

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$13.78

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORC
EYPT
Founded
2010
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Laboratory Analytical Instruments
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2011
2005

Fundamental Metrics

Financial Performance
Metric
ORC
EYPT
Price
$6.94
$13.78
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$7.50
$31.80
AVG Volume (30 Days)
5.2M
1.5M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
17.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,539,000.00
Revenue This Year
$21.28
N/A
Revenue Next Year
$5.71
$3,115.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.42
$9.41
52 Week High
$8.40
$19.11

Technical Indicators

Market Signals
Indicator
ORC
EYPT
Relative Strength Index (RSI) 57.46 50.60
Support Level $6.85 $12.06
Resistance Level $7.00 $14.12
Average True Range (ATR) 0.13 1.10
MACD 0.01 -0.03
Stochastic Oscillator 79.13 27.15

Price Performance

Historical Comparison
ORC
EYPT

About ORC Orchid Island Capital Inc.

Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: